William Wong, Ning Wu, Ravindra Gupta, Aaron Scott Mansfield. Clin Lung Cancer 2021
Times Cited: 7
Times Cited: 7
Times Cited
Times Co-cited
Similarity
The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
Nadia Howlader, Gonçalo Forjaz, Meghan J Mooradian, Rafael Meza, Chung Yin Kong, Kathleen A Cronin, Angela B Mariotto, Douglas R Lowy, Eric J Feuer. N Engl J Med 2020
Nadia Howlader, Gonçalo Forjaz, Meghan J Mooradian, Rafael Meza, Chung Yin Kong, Kathleen A Cronin, Angela B Mariotto, Douglas R Lowy, Eric J Feuer. N Engl J Med 2020
57
Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.
Julia R Trosman, Michael P Douglas, Su-Ying Liang, Christine B Weldon, Allison W Kurian, Robin K Kelley, Kathryn A Phillips. Value Health 2020
Julia R Trosman, Michael P Douglas, Su-Ying Liang, Christine B Weldon, Allison W Kurian, Robin K Kelley, Kathryn A Phillips. Value Health 2020
42
Value of Precision Medicine in Advanced Non-Small Cell Lung Cancer: Real-World Outcomes Associated with the Use of Companion Diagnostics.
Ani John, Roma A Shah, William B Wong, Charles E Schneider, Marliese Alexander. Oncologist 2020
Ani John, Roma A Shah, William B Wong, Charles E Schneider, Marliese Alexander. Oncologist 2020
42
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica Bauman, Lucian R Chirieac, Thomas A D'Amico, Malcolm M DeCamp, Thomas J Dilling, Michael Dobelbower,[...]. J Natl Compr Canc Netw 2017
David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica Bauman, Lucian R Chirieac, Thomas A D'Amico, Malcolm M DeCamp, Thomas J Dilling, Michael Dobelbower,[...]. J Natl Compr Canc Netw 2017
28
Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities.
Martin E Gutierrez, Kelly Choi, Richard B Lanman, Edward J Licitra, Stanley M Skrzypczak, Ruth Pe Benito, Tommy Wu, Srikesh Arunajadai, Sukhi Kaur, Harry Harper,[...]. Clin Lung Cancer 2017
Martin E Gutierrez, Kelly Choi, Richard B Lanman, Edward J Licitra, Stanley M Skrzypczak, Ruth Pe Benito, Tommy Wu, Srikesh Arunajadai, Sukhi Kaur, Harry Harper,[...]. Clin Lung Cancer 2017
28
Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing.
Daniel M Sheinson, William B Wong, Carlos Flores, Sarika Ogale, Cary P Gross. JCO Oncol Pract 2021
Daniel M Sheinson, William B Wong, Carlos Flores, Sarika Ogale, Cary P Gross. JCO Oncol Pract 2021
66
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.
Christine Y Lu, Stephanie Loomer, Rachel Ceccarelli, Kathleen M Mazor, James Sabin, Ellen Wright Clayton, Geoffrey S Ginsburg, Ann Chen Wu. J Pers Med 2018
Christine Y Lu, Stephanie Loomer, Rachel Ceccarelli, Kathleen M Mazor, James Sabin, Ellen Wright Clayton, Geoffrey S Ginsburg, Ann Chen Wu. J Pers Med 2018
28
Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.
Mitchell Reitsma, John Fox, Pierre Vanden Borre, Matthew Cavanaugh, Yakov Chudnovsky, Rachel L Erlich, Thomas E Gribbin, Rachel Anhorn. J Manag Care Spec Pharm 2019
Mitchell Reitsma, John Fox, Pierre Vanden Borre, Matthew Cavanaugh, Yakov Chudnovsky, Rachel L Erlich, Thomas E Gribbin, Rachel Anhorn. J Manag Care Spec Pharm 2019
33
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Nasser H Hanna, Andrew G Robinson, Sarah Temin, Sherman Baker, Julie R Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain,[...]. J Clin Oncol 2021
Nasser H Hanna, Andrew G Robinson, Sarah Temin, Sherman Baker, Julie R Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain,[...]. J Clin Oncol 2021
28
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Frank Griesinger, Wilfried Eberhardt, Arnd Nusch, Marcel Reiser, Mark-Oliver Zahn, Christoph Maintz, Christiane Bernhardt, Christoph Losem, Albrecht Stenzinger, Lukas C Heukamp,[...]. Lung Cancer 2021
Frank Griesinger, Wilfried Eberhardt, Arnd Nusch, Marcel Reiser, Mark-Oliver Zahn, Christoph Maintz, Christiane Bernhardt, Christoph Losem, Albrecht Stenzinger, Lukas C Heukamp,[...]. Lung Cancer 2021
28
Clinical utility of reflex testing using focused next-generation sequencing for management of patients with advanced lung adenocarcinoma.
Tyler E Miller, Michael Yang, David Bajor, Judah D Friedman, Richard Y C Chang, Afshin Dowlati, Joseph E Willis, Navid Sadri. J Clin Pathol 2018
Tyler E Miller, Michael Yang, David Bajor, Judah D Friedman, Richard Y C Chang, Afshin Dowlati, Joseph E Willis, Navid Sadri. J Clin Pathol 2018
28
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.
Charu Aggarwal, Jeffrey C Thompson, Taylor A Black, Sharyn I Katz, Ryan Fan, Stephanie S Yee, Austin L Chien, Tracey L Evans, Joshua M Bauml, Evan W Alley,[...]. JAMA Oncol 2019
Charu Aggarwal, Jeffrey C Thompson, Taylor A Black, Sharyn I Katz, Ryan Fan, Stephanie S Yee, Austin L Chien, Tracey L Evans, Joshua M Bauml, Evan W Alley,[...]. JAMA Oncol 2019
28
Rural definitions for health policy and research.
L Gary Hart, Eric H Larson, Denise M Lishner. Am J Public Health 2005
L Gary Hart, Eric H Larson, Denise M Lishner. Am J Public Health 2005
14
Review of precision cancer medicine: Evolution of the treatment paradigm.
Apostolia M Tsimberidou, Elena Fountzilas, Mina Nikanjam, Razelle Kurzrock. Cancer Treat Rev 2020
Apostolia M Tsimberidou, Elena Fountzilas, Mina Nikanjam, Razelle Kurzrock. Cancer Treat Rev 2020
14
Genome sequencing in microfabricated high-density picolitre reactors.
Marcel Margulies, Michael Egholm, William E Altman, Said Attiya, Joel S Bader, Lisa A Bemben, Jan Berka, Michael S Braverman, Yi-Ju Chen, Zhoutao Chen,[...]. Nature 2005
Marcel Margulies, Michael Egholm, William E Altman, Said Attiya, Joel S Bader, Lisa A Bemben, Jan Berka, Michael S Braverman, Yi-Ju Chen, Zhoutao Chen,[...]. Nature 2005
14
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
Stefania Morganti, Paolo Tarantino, Emanuela Ferraro, Paolo D'Amico, Giulia Viale, Dario Trapani, Bruno Achutti Duso, Giuseppe Curigliano. Crit Rev Oncol Hematol 2019
Stefania Morganti, Paolo Tarantino, Emanuela Ferraro, Paolo D'Amico, Giulia Viale, Dario Trapani, Bruno Achutti Duso, Giuseppe Curigliano. Crit Rev Oncol Hematol 2019
14
Use and Costs for Tumor Gene Expression Profiling Panels in the Management of Breast Cancer From 2006 to 2012: Implications for Genomic Test Adoption Among Private Payers.
Megan C Roberts, Stacie B Dusetzina. J Oncol Pract 2015
Megan C Roberts, Stacie B Dusetzina. J Oncol Pract 2015
14
14
Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.
Carolyn J Presley, Daiwei Tang, Pamela R Soulos, Anne C Chiang, Janina A Longtine, Kerin B Adelson, Roy S Herbst, Weiwei Zhu, Nathan C Nussbaum, Rachael A Sorg,[...]. JAMA 2018
Carolyn J Presley, Daiwei Tang, Pamela R Soulos, Anne C Chiang, Janina A Longtine, Kerin B Adelson, Roy S Herbst, Weiwei Zhu, Nathan C Nussbaum, Rachael A Sorg,[...]. JAMA 2018
14
Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices.
Nathan A Pennell, Maria E Arcila, David R Gandara, Howard West. Am Soc Clin Oncol Educ Book 2019
Nathan A Pennell, Maria E Arcila, David R Gandara, Howard West. Am Soc Clin Oncol Educ Book 2019
14
Rural veterans and access to high-quality care for high-risk surgeries.
Alan N West, William B Weeks, Amy E Wallace. Health Serv Res 2008
Alan N West, William B Weeks, Amy E Wallace. Health Serv Res 2008
14
Next Generation Sequencing and Multi-Gene Panel Testing: Implications for the Oncology Nurse.
Patricia A Kelly. Semin Oncol Nurs 2017
Patricia A Kelly. Semin Oncol Nurs 2017
14
Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology.
John Marquart, Emerson Y Chen, Vinay Prasad. JAMA Oncol 2018
John Marquart, Emerson Y Chen, Vinay Prasad. JAMA Oncol 2018
14
Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data.
Julie A Lynch, Brygida Berse, W David Dotson, Muin J Khoury, Nicole Coomer, John Kautter. Genet Med 2017
Julie A Lynch, Brygida Berse, W David Dotson, Muin J Khoury, Nicole Coomer, John Kautter. Genet Med 2017
14
Genetic testing utilization for patients with neurologic disease and the limitations of claims data.
Samuel J Mackenzie, Chun Chieh Lin, Peter K Todd, James F Burke, Brian C Callaghan. Neurol Genet 2020
Samuel J Mackenzie, Chun Chieh Lin, Peter K Todd, James F Burke, Brian C Callaghan. Neurol Genet 2020
50
Clinical Outcomes, Treatment Patterns, and Health Resource Utilization Among Metastatic Breast Cancer Patients with Germline BRCA1/2 Mutation: A Real-World Retrospective Study.
Ruben G W Quek, Jack Mardekian. Adv Ther 2019
Ruben G W Quek, Jack Mardekian. Adv Ther 2019
14
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Erik von Elm, Douglas G Altman, Matthias Egger, Stuart J Pocock, Peter C Gøtzsche, Jan P Vandenbroucke. Epidemiology 2007
Erik von Elm, Douglas G Altman, Matthias Egger, Stuart J Pocock, Peter C Gøtzsche, Jan P Vandenbroucke. Epidemiology 2007
14
Utilization of tumor genomics in clinical practice: an international survey among ASCO members.
Romualdo Barroso-Sousa, Hao Guo, Piyush Srivastava, Ted James, Walter Birch, Lillian L Siu, William P Tew, Sara M Tolaney. Future Oncol 2019
Romualdo Barroso-Sousa, Hao Guo, Piyush Srivastava, Ted James, Walter Birch, Lillian L Siu, William P Tew, Sara M Tolaney. Future Oncol 2019
16
Racial/ethnic and gender disparities in the use of erythropoiesis-stimulating agents and blood transfusions: cancer management under Medicare's reimbursement policy.
Minghui Li, Richard Schulz, Marie Chisholm-Burns, Junling Wang, Z Kevin Lu. J Manag Care Spec Pharm 2020
Minghui Li, Richard Schulz, Marie Chisholm-Burns, Junling Wang, Z Kevin Lu. J Manag Care Spec Pharm 2020
50
Bariatric surgery in minority patients before and after implementation of a centers of excellence program.
Lauren Hersch Nicholas, Justin B Dimick. JAMA 2013
Lauren Hersch Nicholas, Justin B Dimick. JAMA 2013
14
Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practices.
Eric D Whitman, Frank Xiaoqing Liu, Xiting Cao, Scott J Diede, Amin Haiderali, Amy P Abernethy. Future Oncol 2019
Eric D Whitman, Frank Xiaoqing Liu, Xiting Cao, Scott J Diede, Amin Haiderali, Amy P Abernethy. Future Oncol 2019
14
Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status.
Gary V Walker, Stephen R Grant, B Ashleigh Guadagnolo, Karen E Hoffman, Benjamin D Smith, Matthew Koshy, Pamela K Allen, Usama Mahmood. J Clin Oncol 2014
Gary V Walker, Stephen R Grant, B Ashleigh Guadagnolo, Karen E Hoffman, Benjamin D Smith, Matthew Koshy, Pamela K Allen, Usama Mahmood. J Clin Oncol 2014
14
Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USA.
Lisa M Hess, Zhanglin Lin Cui, Daniel S Mytelka, Yimei Han, Robert Goodloe, William Schelman. Int J Colorectal Dis 2019
Lisa M Hess, Zhanglin Lin Cui, Daniel S Mytelka, Yimei Han, Robert Goodloe, William Schelman. Int J Colorectal Dis 2019
16
Validation analysis of a composite real-world mortality endpoint for patients with cancer in the United States.
Qianyi Zhang, Anala Gossai, Shirley Monroe, Nathan C Nussbaum, Christina M Parrinello. Health Serv Res 2021
Qianyi Zhang, Anala Gossai, Shirley Monroe, Nathan C Nussbaum, Christina M Parrinello. Health Serv Res 2021
14
Barriers to clinical adoption of next generation sequencing: Perspectives of a policy Delphi panel.
Donna A Messner, Jennifer Al Naber, Pei Koay, Robert Cook-Deegan, Mary Majumder, Gail Javitt, Patricia Deverka, Rachel Dvoskin, Juli Bollinger, Margaret Curnutte,[...]. Appl Transl Genom 2016
Donna A Messner, Jennifer Al Naber, Pei Koay, Robert Cook-Deegan, Mary Majumder, Gail Javitt, Patricia Deverka, Rachel Dvoskin, Juli Bollinger, Margaret Curnutte,[...]. Appl Transl Genom 2016
14
Crizotinib in Chinese Patients with ROS1-Rearranged Advanced Non‒Small-Cell Lung Cancer in Routine Clinical Practice.
Chang Liu, Hui Yu, Jianhua Chang, Haiquan Chen, Yuan Li, Weixin Zhao, Kuaile Zhao, Zhengfei Zhu, Si Sun, Min Fan,[...]. Target Oncol 2019
Chang Liu, Hui Yu, Jianhua Chang, Haiquan Chen, Yuan Li, Weixin Zhao, Kuaile Zhao, Zhengfei Zhu, Si Sun, Min Fan,[...]. Target Oncol 2019
14
14
Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
Julien Mazières, Gérard Zalcman, Lucio Crinò, Pamela Biondani, Fabrice Barlesi, Thomas Filleron, Anne-Marie C Dingemans, Hervé Léna, Isabelle Monnet, Sacha I Rothschild,[...]. J Clin Oncol 2015
Julien Mazières, Gérard Zalcman, Lucio Crinò, Pamela Biondani, Fabrice Barlesi, Thomas Filleron, Anne-Marie C Dingemans, Hervé Léna, Isabelle Monnet, Sacha I Rothschild,[...]. J Clin Oncol 2015
14
Comparisons of Real-World Time-to-Event End Points in Oncology Research.
Brigham Walker, Marley Boyd, Kat Aguilar, Kalatu Davies, Janet Espirito, Jennifer Frytak, Nicholas Robert. JCO Clin Cancer Inform 2021
Brigham Walker, Marley Boyd, Kat Aguilar, Kalatu Davies, Janet Espirito, Jennifer Frytak, Nicholas Robert. JCO Clin Cancer Inform 2021
25
Novel targets in non-small cell lung cancer: ROS1 and RET fusions.
Justin F Gainor, Alice T Shaw. Oncologist 2013
Justin F Gainor, Alice T Shaw. Oncologist 2013
14
Identifying and targeting ROS1 gene fusions in non-small cell lung cancer.
Kurtis D Davies, Anh T Le, Mariana F Theodoro, Margaret C Skokan, Dara L Aisner, Eamon M Berge, Luigi M Terracciano, Federico Cappuzzo, Matteo Incarbone, Massimo Roncalli,[...]. Clin Cancer Res 2012
Kurtis D Davies, Anh T Le, Mariana F Theodoro, Margaret C Skokan, Dara L Aisner, Eamon M Berge, Luigi M Terracciano, Federico Cappuzzo, Matteo Incarbone, Massimo Roncalli,[...]. Clin Cancer Res 2012
14
Understanding Contemporary Molecular Biomarker Testing Rates and Trends for Metastatic NSCLC Among Community Oncologists.
David M Waterhouse, Wan-Yu Tseng, Janet L Espirito, Nicholas J Robert. Clin Lung Cancer 2021
David M Waterhouse, Wan-Yu Tseng, Janet L Espirito, Nicholas J Robert. Clin Lung Cancer 2021
50
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond.
Sai-Hong Ignatius Ou. Drug Des Devel Ther 2011
Sai-Hong Ignatius Ou. Drug Des Devel Ther 2011
14
ALK, lung cancer, and personalized therapy: portent of the future?
Ken Garber. J Natl Cancer Inst 2010
Ken Garber. J Natl Cancer Inst 2010
14
Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.
Yi-Long Wu, James Chih-Hsin Yang, Dong-Wan Kim, Shun Lu, Jianying Zhou, Takashi Seto, Jin-Ji Yang, Noboru Yamamoto, Myung-Ju Ahn, Toshiaki Takahashi,[...]. J Clin Oncol 2018
Yi-Long Wu, James Chih-Hsin Yang, Dong-Wan Kim, Shun Lu, Jianying Zhou, Takashi Seto, Jin-Ji Yang, Noboru Yamamoto, Myung-Ju Ahn, Toshiaki Takahashi,[...]. J Clin Oncol 2018
14
Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer.
C Lim, M S Tsao, L W Le, F A Shepherd, R Feld, R L Burkes, G Liu, S Kamel-Reid, D Hwang, J Tanguay,[...]. Ann Oncol 2015
C Lim, M S Tsao, L W Le, F A Shepherd, R Feld, R L Burkes, G Liu, S Kamel-Reid, D Hwang, J Tanguay,[...]. Ann Oncol 2015
14
Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
14
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.
A T Shaw, G J Riely, Y-J Bang, D-W Kim, D R Camidge, B J Solomon, M Varella-Garcia, A J Iafrate, G I Shapiro, T Usari,[...]. Ann Oncol 2019
A T Shaw, G J Riely, Y-J Bang, D-W Kim, D R Camidge, B J Solomon, M Varella-Garcia, A J Iafrate, G I Shapiro, T Usari,[...]. Ann Oncol 2019
14
Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial.
Lorenza Landi, Rita Chiari, Marcello Tiseo, Federica D'Incà, Claudio Dazzi, Antonio Chella, Angelo Delmonte, Laura Bonanno, Diana Giannarelli, Diego Luigi Cortinovis,[...]. Clin Cancer Res 2019
Lorenza Landi, Rita Chiari, Marcello Tiseo, Federica D'Incà, Claudio Dazzi, Antonio Chella, Angelo Delmonte, Laura Bonanno, Diana Giannarelli, Diego Luigi Cortinovis,[...]. Clin Cancer Res 2019
14
BRAF in Lung Cancers: Analysis of Patient Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent Alterations.
Yuri Sheikine, Dean Pavlick, Samuel J Klempner, Sally E Trabucco, Jon H Chung, Mark Rosenzweig, Kai Wang, Vamsidhar Velcheti, Garrett M Frampton, Nir Peled,[...]. JCO Precis Oncol 2018
Yuri Sheikine, Dean Pavlick, Samuel J Klempner, Sally E Trabucco, Jon H Chung, Mark Rosenzweig, Kai Wang, Vamsidhar Velcheti, Garrett M Frampton, Nir Peled,[...]. JCO Precis Oncol 2018
14
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.